ATE218881T1 - Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin - Google Patents

Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin

Info

Publication number
ATE218881T1
ATE218881T1 AT99917867T AT99917867T ATE218881T1 AT E218881 T1 ATE218881 T1 AT E218881T1 AT 99917867 T AT99917867 T AT 99917867T AT 99917867 T AT99917867 T AT 99917867T AT E218881 T1 ATE218881 T1 AT E218881T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
ezrine
containing mutated
mutated tyrosine
Prior art date
Application number
AT99917867T
Other languages
English (en)
Inventor
Monique Arpin
Tiziana Crepaldi
Alexis Gautreau
Daniel Louvard
Original Assignee
Inst Curie
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Curie, Centre Nat Rech Scient filed Critical Inst Curie
Application granted granted Critical
Publication of ATE218881T1 publication Critical patent/ATE218881T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99917867T 1998-03-18 1999-03-18 Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin ATE218881T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/040,725 US6399584B1 (en) 1998-03-18 1998-03-18 Pharmaceutical composition containing ezrin mutated on tyrosine 353
PCT/EP1999/002054 WO1999047150A2 (en) 1998-03-18 1999-03-18 A pharmaceutical composition containing ezrin mutated on tyrosine 353

Publications (1)

Publication Number Publication Date
ATE218881T1 true ATE218881T1 (de) 2002-06-15

Family

ID=21912598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99917867T ATE218881T1 (de) 1998-03-18 1999-03-18 Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin

Country Status (6)

Country Link
US (2) US6399584B1 (de)
EP (1) EP1061941B1 (de)
AT (1) ATE218881T1 (de)
AU (1) AU3600199A (de)
DE (1) DE69901805T2 (de)
WO (1) WO1999047150A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2354241A (en) * 1999-09-17 2001-03-21 Rupert Donald Holms Regulatory/unfolding peptides of ezrin
JP2004536585A (ja) 2001-05-09 2004-12-09 エール・ユニバーシティ トル／インターロイキン−１受容体アダプタータンパク質（ｔｉｒａｐ）
AU2003257960A1 (en) * 2002-08-01 2004-03-03 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Cell modulation using a cytoskeletal protein
AU2004234076A1 (en) * 2003-04-30 2004-11-11 Laboratoires Serono Sa Beta-amyloid inhibitors and use thereof
WO2005060996A2 (en) * 2003-12-23 2005-07-07 Lauras As Method of altering the pka type i signalling pathway
EP1786445B1 (de) * 2004-08-25 2011-06-08 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Lebendige mikrobielle mikrobizide
CA2569080A1 (en) * 2006-11-20 2008-05-20 Institut Pasteur Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
WO2009103312A1 (en) * 2008-02-19 2009-08-27 Ludwig-Maximilians-Universität Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
WO2011036211A1 (en) 2009-09-23 2011-03-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptides and nucleic acids for treating erbb2-dependent cancers

Also Published As

Publication number Publication date
AU3600199A (en) 1999-10-11
WO1999047150A2 (en) 1999-09-23
DE69901805T2 (de) 2003-03-06
EP1061941B1 (de) 2002-06-12
US6399584B1 (en) 2002-06-04
WO1999047150A3 (en) 2000-01-20
DE69901805D1 (de) 2002-07-18
WO1999047150A9 (en) 1999-11-18
US20020115633A1 (en) 2002-08-22
EP1061941A2 (de) 2000-12-27

Similar Documents

Publication Publication Date Title
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
MD960330A (ro) Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
ES2178157T3 (es) Tratamiento de arritmias mediante la inhibicion de una proteina quinasa multifuncional dependiente de calcio/calmodulina.
ID26639A (id) Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
EP1231914A4 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE221881T1 (de) Tetralin-verbindungen mit multi-drugresistenz (mdr)-aktivitat
NO20004419L (no) Ny anvendelse
YU13301A (sh) Muskarinski agonisti i antagonisti
TR199800270T1 (xx) Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�.
BR0108728A (pt) Combinação farmacêutica terapêutica, e, método para tratar um c ncer.
EE03420B1 (et) Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
DE69619052D1 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DE69901805D1 (de) Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
ZA947894B (en) Compounds for medicinal use
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer